Skip to main content
AVECHO BIOTECHNOLOGY LIMITED logo

AVECHO BIOTECHNOLOGY LIMITED — Investor Relations & Filings

Ticker · AVE ISIN · AU0000047441 LEI · 529900FA9G9T82C2LV25 ASX Manufacturing
Open in API
Filings indexed 881 across all filing types
Latest filing 2013-07-24 Regulatory Filings
Country AU Australia
Listing ASX AVE

About AVECHO BIOTECHNOLOGY LIMITED

https://avecho.com.au/

Avecho Biotechnology Limited develops and commercializes human and animal health products using its proprietary drug delivery system, Tocopheryl Phosphate Mixture (TPM®). Derived from Vitamin E, TPM® is designed to enhance the solubility and absorption of active ingredients through the skin and digestive tract. The company focuses on applying this technology to pharmaceuticals, nutraceuticals, and animal health sectors. A primary area of development includes medicinal cannabis, where Avecho has produced high-bioavailability cannabidiol (CBD) softgel capsules for therapeutic use. The company’s portfolio also includes applications in pain management and dermatology, leveraging TPM® to improve the delivery of poorly soluble molecules and enhance the efficacy of existing treatments.

Recent filings

Filing Released Lang Actions
Misappropriations Investigation - Clarification 1 p
Regulatory Filings Classification · 95% confidence The document is a clarification announcement regarding a previous announcement about an investigation into invoicing and accounting misappropriations. It does not contain financial statements, audit results, or detailed management discussion. It is a regulatory announcement clarifying facts about an internal investigation and allegations. The document is short (2372 characters) and serves as a public clarification rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2013-07-24 English
Invoicing and Accounting Misappropriations Investigation 2 pages 44.4KB
Legal Proceedings Report Classification · 95% confidence The document is an announcement from Phosphagenics Limited regarding an investigation into invoicing and accounting misappropriations. It details the findings of a forensic investigation, dismissal of an employee, allegations against others, and steps taken by the company to recover funds. The content focuses on legal and internal control issues rather than financial results or reports. There is no presentation of financial statements or detailed financial data, nor is it a regulatory certification or a report publication notice. The document is best classified as a Legal Proceedings Report (LTR) because it updates on significant internal fraud investigations and related legal actions.
2013-07-23 English
Appendix 3Z Final Director's Interest Notice - Dr E Ogru 3 pages 313.7KB
Director's Dealing Classification · 100% confidence The document is titled 'Change in Directors Interest' and includes an Appendix 3Z (Final Director’s Interest Notice) related to the resignation of a director, Dr E Ogru. It details the director's securities holdings and relevant interests, consistent with insider trading or director dealing disclosures. The document is short (3599 characters) and is a formal announcement of a director's share transactions and interests, not a financial report or management discussion. This matches the definition of Director's Dealing (DIRS).
2013-07-23 English
Resignation of Executive Director 1 page 36.4KB
Board/Management Information Classification · 100% confidence The document is a short announcement from Phosphagenics Limited regarding the resignation of an executive director, Dr Esra Ogru. It mentions the resignation date and upcoming investigation findings but does not contain financial data, report content, or detailed management discussion. The document is clearly about a change in senior management. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on management change, confirming this classification.
2013-07-21 English
Phosphagenics to Launch Phase 2 Acne Treatment Trial 2 pages 149.5KB
Regulatory Filings Classification · 95% confidence The document is a market announcement from Phosphagenics Limited about the launch of a Phase 2 clinical trial for an acne treatment product. It provides details about the trial, the product, and company background. There are no financial statements, regulatory certifications, voting results, or management changes. The content is a corporate update on a clinical trial commencement, which fits best under general regulatory announcements or company news. The document length is 3849 characters, which is relatively short and does not contain financial data or detailed report content. Therefore, it is not an Annual Report, Interim Report, Earnings Release, or similar. It is not a report publication announcement either, as it contains substantive information about the trial launch. The best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous company announcements that do not fit other categories.
2013-07-11 English
Invoicing and Accounting Irregularities 1 page 38.4
Board/Management Information Classification · 95% confidence The document is a short announcement from Phosphagenics Limited regarding identified invoicing and accounting irregularities, the suspension of the CEO, and the appointment of an interim CEO. It mentions an ongoing investigation and provides some financial context but does not contain detailed financial statements or comprehensive financial data. The document is brief (2265 characters) and serves as a regulatory update on management and accounting issues rather than a full report or detailed financial disclosure. It does not fit into categories like Annual Report, Interim Report, or Audit Report. It is primarily an announcement of management changes and investigation status, which aligns best with Board/Management Information (MANG).
2013-06-30 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.